Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
UTHRthis companyUnited Therapeutics Corporation	$562.20	16.17×	3.04×	6.78×	11.03×	23.4%	87.9%	47.7%	41.9%	18.8%	16.1%	4.8%	0.01×	-0.84×	77.81×	6.6×	0.0%	6	22.22	4	A-
IKTInhibikase Therapeutics, Inc.	$1.62	-4.18×	1.17×	0×	-1.17×	-8.7%	0.0%	0.0%	0.0%	-27.9%	-30.1%	-13.8%	0×	2.61×	0×	21.7×	0.0%	2	10.89	2	C
INSMInsmed Incorporated	$114.89	-27.15×	50.31×	61.31×	-31.96×	-253.3%	79.4%	-194.0%	-210.5%	-172.8%	-64.8%	-2.6%	1.04×	-0.22×	-14.04×	3.83×	0.0%	4	6.45	1	D+
LQDALiquidia Corporation	$47.41	-43.11×	66.33×	18.75×	-68.84×	-288.6%	91.6%	-32.5%	-43.5%	-154.0%	-20.5%	-1.3%	4.42×	-0.17×	-2.13×	1.4×	0.0%	6	8.09	3	B-
TVTXTravere Therapeutics, Inc.	$50.45	-68.23×	29.69×	6.95×	164.03×	-591.5%	97.9%	-12.8%	-5.2%	-22.2%	-13.9%	-0.6%	2.86×	10.61×	-5.85×	2.74×	0.0%	4	1.52	1	D+
Peer median	—	-35.13×	40×	12.85×	-16.56×	-271.0%	85.5%	-22.6%	-24.4%	-91.0%	-25.3%	-2.0%	1.95×	1.22×	-3.99×	3.28×	0.0%	4	7.27	2	—